Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices On February 20, 2013, the Advisory Committee on Immunization Practices recommended routine use of 13-valent ... (more)
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6225a3.htm?s_cid=mm6225a3_x
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6225a3.htm?s_cid=mm6225a3_x
No comments:
Post a Comment